Clinical trial
Warfarin Versus Aspirin Recurrent Stroke Study
NCT00027066 · Columbia University, Other · Completed
Key facts
| NCT number | NCT00027066 |
|---|---|
| Title | Warfarin Versus Aspirin Recurrent Stroke Study |
| Official title | A Comparison of Warfarin and Aspirin for the Prevention of Recurrent Ischemic Stroke |
| Lead sponsor | Columbia University, Other |
| Collaborators | National Institute of Neurological Disorders and Stroke (NINDS) NIH |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Stroke |
| Intervention type | Drug |
| Interventions | Active Aspirin, Active Warfarin, Aspirin placebo, Warfarin placebo |
| Enrollment | 2,206 |
| Start date | Jun 1, 1993 |
| Primary completion | Jun 1, 2000 |
| Completion | Nov 1, 2001 |
| First posted | Nov 21, 2001 |
| Last update posted | Jun 17, 2011 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: